Share “News Summary: Amgen Q4 net jumps on higher...”

News Summary: Amgen Q4 net jumps on higher sales

Published on NewsOK Modified: January 28, 2014 at 6:17 pm •  Published: January 28, 2014
Advertisement

THE BOTTOM LINE: A tax benefit, an acquisition and price hikes that boosted drug revenue helped Amgen, the world's biggest maker of biologic drugs, increase fourth-quarter profit by 30 percent.

THE NUMBERS: Net income was $1.02 billion, while adjusted profit was $1.39 billion, or $1.82 per share — 13 cents more than analysts expected. Revenue totaled $5.01 billion, up 13 percent.

THE FUTURE: Amgen forecast 2014 adjusted earnings per share of $7.90 to $8.20, disappointing investors and sending shares down 1 percent in after-hours trading. However, the company has some promising drugs in late testing.


AROUND THE WEB

  1. 1
    Dispute: Was Cecil the lion's brother, Jericho, killed?
  2. 2
    An Oklahoma Immigrant's Experience, Recast As Noir, In 'Dragonfish'
  3. 3
    Summer well spent: Youths shadow professionals in mentoring program
  4. 4
    Norman residents disturbed after seeing vulgar, racist graffiti on homes, vehicles
  5. 5
    Vinita police chief: Extreme sunburn case still under investigation, drawing international media...
+ show more

FEATURED JOBS



× Trending health Article